Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (Weighted Average) (2020 - 2025)

Bio Essence (BIOE) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $38.0 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $38.0 million; the TTM value through Sep 2025 reached $38.0 million, changed 0.0%, while the annual FY2024 figure was $38.0 million, 11.94% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $38.0 million in Q3 2025 per BIOE's latest filing, roughly flat from $38.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $38.0 million in Q3 2023 and bottomed at $33.0 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $35.2 million, with a median of $33.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 0.23% in 2021, then rose 15.15% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then grew by 2.86% to $34.0 million in 2023, then increased by 11.94% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $38.0 million in Q3 2025, $38.0 million in Q2 2025, and $38.0 million in Q1 2025.